Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.
Peter Malfertheiner, Francis Megraud, Theodore Rokkas...
https://pubmed.ncbi.nlm.nih.gov/35944925/Actively Recruiting
Led by Clinique Bizet · Updated on 2026-10-27
250
Participants Needed
1
Research Sites
22 weeks
Total Duration
Researchers are evaluating the use of real-time PCR qPCR on formalin-fixed, paraffin-embedded FFPE gastric biopsy samples to detect Helicobacter pylori infection and clarithromycin resistance. The study aims to determine if qPCR on routine tissue samples can reliably identify H. pylori and resistance mutations, comparing results with histology, immunohistochemistry, and bacteriological PCR. This observational study focuses on adults suspected of H. pylori infection needing gastric biopsies during gastroscopy. Participants will have gastric biopsies collected during their routine gastroscopy, with qPCR performed on FFPE tissue blocks to detect H. pylori and clarithromycin resistance mutations. The study will measure the diagnostic performance of qPCR, including sensitivity, specificity, result availability, and time to results. Secondary goals include evaluating mutation prevalence, concordance with other tests, therapeutic impact, and medical-economic outcomes related to this diagnostic strategy. During the study, participants will undergo routine gastroscopy with biopsy collection, followed by pathology and bacteriology analyses as per the study protocol. Researchers will assess diagnostic accuracy within 10 to 15 days after biopsy, track impact on treatment decisions, and monitor economic aspects over about 12 months. The participation period includes a 10-day follow-up after inclusion, with no changes to usual clinical care.
CONDITIONS
Feasibility and Performance of FFPE qPCR for Detection of Clarithromycin Resistance in Helicobacter Pylori
B
Bouchra BENKESSOU
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Clinique Bizet
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 days after biopsy
Participants undergo routine gastroscopy with gastric biopsies collected for pathology and bacteriology testing. Additional qPCR testing is performed on biopsy samples to detect H. pylori and clarithromycin resistance mutations.
1 biopsy procedure visit
Duration - Approximately 12 months
Researchers assess test results and their impact on treatment decisions and medical-economic outcomes over about 12 months.
Follow-up assessments at regular intervals
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Peter Malfertheiner, Francis Megraud, Theodore Rokkas...
https://pubmed.ncbi.nlm.nih.gov/35944925/Bryan H Schmitt, Maryann Regner, Kathy A Mangold...
https://pubmed.ncbi.nlm.nih.gov/23579617/Behtash G Nezami, Mehul Jani, David Alouani...
https://pubmed.ncbi.nlm.nih.gov/31068413/Monica Oleastro, Armelle Ménard, Adriana Santos...
https://pubmed.ncbi.nlm.nih.gov/12517879/Clinique Bizet
Lead Sponsor